The Indiana Alzheimer Disease Center (IADC) is established on the facilities of Indiana University School of Medicine. It will comprise five cores: an Administrative Core, Clinical Core, Data Management and Statistics Core, Neuropathology Core, and an Education and Information Transfer Core. The Director and two Associate Co-Directors of the Center are Dr. Bernardino Ghetti (Distinguished Professor of Pathology & Laboratory Medicine, Psychiatry, Medical & Molecular Genetics, and Neurology), Dr. Hugh C. Hendrie (Professor of Psychiatry) and Dr. Martin R. Farlow (Professor of Neurology). ? ? The strength of the IADC lays in its multidisciplinary faculty that has contributed significantly in the fields of Psychiatry, Neurology, Neuropathology, Medical and Molecular Genetics. The IADC interacts with other multidisciplinary clinical and research programs at Indiana University, the graduate programs in Medical Neurobiology and Genetics, the Indiana University Center for Aging Research and the Stark Neurosciences Research Institute. The Core Leaders have an established record in medical care, research related to Alzheimer disease (AD) and related dementias with particular emphasis on hereditary dementias. ? ? The IADC has developed and will continue to foster community relationships and educational programs in cooperation with the Alzheimer's Association, Central Indiana Chapter and other community agencies. The major strengths of the IADC are the clinicopathologic and molecular studies on atypical and hereditary dementias, the trials for new drug therapy for AD, and other hereditary dementias, and the educational activities. ? ? The IADC will continue to support research endeavors in dementia by facilitating research interactions, sharing knowledge of faculty and their laboratory facilities, and providing an environment to faculty, graduates and students of Indiana University School of Medicine that generates interest in dementia research. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010133-17
Application #
7267725
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (M1))
Program Officer
Phelps, Creighton H
Project Start
1997-07-15
Project End
2011-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
17
Fiscal Year
2007
Total Cost
$1,330,156
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pathology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Campbell, Noll L; Lane, Kathleen A; Gao, Sujuan et al. (2018) Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care. Pharmacotherapy 38:511-519
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Yan, Jingwen; Liu, Kefei; Li, Huang et al. (2018) JOINT EXPLORATION AND MINING OF MEMORY-RELEVANT BRAIN ANATOMIC AND CONNECTOMIC PATTERNS VIA A THREE-WAY ASSOCIATION MODEL. Proc IEEE Int Symp Biomed Imaging 2018:6-9
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Murray, Michael D; Hendrie, Hugh C; Lane, Kathleen A et al. (2018) Antihypertensive Medication and Dementia Risk in Older Adult African Americans with Hypertension: A Prospective Cohort Study. J Gen Intern Med 33:455-462
Wang, Sophia; Allen, Duane; Kheir, You Na et al. (2018) Aging and Post-Intensive Care Syndrome: A Critical Need for Geriatric Psychiatry. Am J Geriatr Psychiatry 26:212-221
Apostolova, Liana G; Risacher, Shannon L; Duran, Tugce et al. (2018) Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis. JAMA Neurol 75:328-341
Wang, Xiaoqian; Chen, Hong; Yan, Jingwen et al. (2018) Quantitative trait loci identification for brain endophenotypes via new additive model with random networks. Bioinformatics 34:i866-i874
Li, Wei; Risacher, Shannon L; Gao, Sujuan et al. (2018) Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid ?1-42 in Alzheimer's Disease Neuroimaging Initiative participants. Alzheimers Dement (Amst) 10:94-98

Showing the most recent 10 out of 604 publications